Comparison of the efficacy of adalimumab versus golimumab in moderate-to-severe ulcerative colitis.
Phase of Trial: Phase IV
Latest Information Update: 06 Dec 2017
At a glance
- Drugs Adalimumab (Primary) ; Golimumab (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- 06 Dec 2017 New trial record
- 01 Nov 2017 Results presented at the 25th United European Gastroenterology Week.